Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with parkinson’s disease

Tino Prell*, Denise Schaller, Caroline Perner, Gabriele Helga Franke, Otto W. Witte, Albrecht Kunze, Julian Grosskreutz

*Corresponding author for this work
9 Citations (Scopus)

Abstract

Purpose: Adherence to medication can be assessed by various self-report questionnaires. One could hypothesize that survey respondents tend to answer questions in a manner that will be viewed favorably by others. We aimed to answer if anonymous and nonanonymous responses to a questionnaire on medication adherence differ. Patients and methods: Adherence was assessed with the German Stendal Adherence with Medication Score (SAMS), which includes 18 questions with responses based on a 5-point Likert scale. Anonymous data from 40 subjects were collected during a symposium for patients with Parkinson’s disease (PD), and nonanonymous data were obtained from 40 outpatient-clinic PD patients at the Department of Neurology. Results: The two groups (anonymous self-reported questionnaire and nonanonymous) did not differ in terms of demographical characteristics and the SAMS sum score. However, anonymously collected data showed significant higher scoring for the item 6 (“Do you forget your medications?”) than the data collected nonanonymously (P=0.017). All other items of the SAMS did not significantly differ between both groups. Conclusion: Overall assessment of adherence does not depend on whether the patient remains anonymous or not. There seems to be no relevant social desirability bias in nonanonymous responses.

Original languageEnglish
JournalPatient Preference and Adherence
Volume13
Pages (from-to)151-155
Number of pages5
ISSN1177-889X
DOIs
Publication statusPublished - 2019
Externally publishedYes

Research Areas and Centers

  • Centers: Center for Neuromuscular Diseases

Cite this